Bancorp. of Southern Indiana (BCSO)
USD 47.0
(0.0%)
USD 47.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 36.41 Million | 36.59 Million | 36.53 Million | 35.62 Million | 30.96 Million | 26.18 Million |
| Cost of Revenue | -15.25 Million | - | - | - | - | - |
| Gross Profit | 51.67 Million | 36.59 Million | 36.53 Million | 35.62 Million | 30.96 Million | 26.18 Million |
| Operating Expenses | 37.31 Million | 7.81 Million | 16.31 Million | 15.57 Million | 19.07 Million | 17.16 Million |
| Selling, General and Administrative Expenses | 37.31 Million | - | - | - | - | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | -7.81 Million | -6.4 Million | -5.73 Million | - | -21.16 Million |
| Cost and Expenses | 22.06 Million | 28.07 Million | 25.97 Million | 27.41 Million | 24.46 Million | 21.16 Million |
| Operating Income | 36.41 Million | 8.52 Million | 10.56 Million | 8.2 Million | 6.49 Million | 5.01 Million |
| Interest Expense | 14.35 Million | 4.13 Million | 3.25 Million | 4.31 Million | 4.96 Million | - |
| Income Tax Expense | 1.16 Million | 1.26 Million | 1.68 Million | 1.25 Million | 965 Thousand | 698 Thousand |
| Earnings before Tax | 7.97 Million | 8.52 Million | 10.56 Million | 8.2 Million | 6.49 Million | 5.01 Million |
| Net Income | 6.81 Million | 7.25 Million | 8.87 Million | 6.95 Million | 5.53 Million | 4.31 Million |
| Earnings Per Share Basic | 5.04 | 5.36 | 6.54 | 5.12 | 4.08 | 3.18 |
| Earnings Per Share Diluted | 5.04 | 5.36 | 6.54 | 5.12 | 4.08 | 3.18 |
| Weighted Average Shares Outstanding | 1.35 Million | 1.35 Million | 1.35 Million | 1.35 Million | 1.35 Million | 1.35 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.35 Million | 1.35 Million | 1.35 Million | 1.35 Million | 1.35 Million | 1.35 Million |
| Gross Margin | 1.42 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | 0.25 | 0.29 | 0.29 | 0.23 | 0.21 | 0.19 |
| Profit Margin | 0.19 | 0.20 | 0.24 | 0.20 | 0.18 | 0.16 |
| EBITDA | 9.19 Million | 10.2 Million | 12.19 Million | 9.63 Million | 7.65 Million | 5.01 Million |
| Earnings Before Tax Margin | 1.00 | 0.23 | 0.29 | 0.23 | 0.21 | 0.19 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 6.77 Million | 6.63 Million | 6.92 Million | 51.67 Million | 6.68 Million | 6.56 Million |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 6.77 Million | 6.63 Million | 6.92 Million | 51.67 Million | 6.68 Million | 6.56 Million |
| Operating Expenses | - | - | - | 9.19 Million | - | - |
| Selling, General and Administrative Expenses | - | - | - | - | - | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | -9.19 Million | - | - |
| Cost and Expenses | - | - | - | 43.69 Million | - | - |
| Operating Income | 6.77 Million | 6.63 Million | 6.92 Million | 7.97 Million | 6.68 Million | 6.56 Million |
| Interest Expense | - | - | - | 14.35 Million | - | - |
| Income Tax Expense | - | - | - | 1.16 Million | 6.72 Million | 6.44 Million |
| Earnings before Tax | 6.77 Million | 6.63 Million | 6.92 Million | 7.97 Million | 6.68 Million | 6.56 Million |
| Net Income | 6.77 Million | 6.63 Million | 6.92 Million | 6.81 Million | 6.68 Million | 6.56 Million |
| Earnings Per Share Basic | 4.99 | 0.98 | 1.73 | - | 0.88 | 3.53 |
| Earnings Per Share Diluted | 4.99 | 0.98 | 1.73 | - | 0.88 | - |
| Weighted Average Shares Outstanding | 1.35 Million | 1.35 Million | 1.35 Million | 1.35 Million | 1.35 Million | - |
| Weighted Average Shares Outstanding (Diluted) | 1.35 Million | 1.35 Million | 1.35 Million | 1.35 Million | 1.35 Million | - |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | 1.00 | - | 0.01 | - | 1.00 | 1.00 |
| Profit Margin | 1.00 | 1.00 | 1.00 | 0.13 | 1.00 | 1.00 |
| EBITDA | 6.77 Million | - | 43.81 Thousand | - | 6.68 Million | 6.56 Million |
| Earnings Before Tax Margin | 1.00 | 1.00 | 1.00 | 0.15 | 1.00 | 1.00 |
3311
BORORENEW
BIOTEC
GHCL
1512
1009